| scholarly article | Q13442814 |
| P50 | author | Ulf Andersson | Q37375023 |
| Karin Palmblad | Q58739051 | ||
| P2093 | author name string | Heidi Wähämaa | |
| Ann-Charlotte Aveberger | |||
| Hanna Schierbeck | |||
| Helena Erlandsson Harris | |||
| Therese Ostberg | |||
| Lars Ottosson | |||
| Lena Klevenvall | |||
| Hulda Sigridur Hreggvidsdottir | |||
| P2860 | cites work | HMGB1: endogenous danger signaling | Q24645232 |
| Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
| HMG-1 as a late mediator of endotoxin lethality in mice | Q28139166 | ||
| High mobility group box 1 protein interacts with multiple Toll-like receptors | Q28280114 | ||
| Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation | Q28572865 | ||
| High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes | Q28574795 | ||
| Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy | Q29619961 | ||
| Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE | Q29620722 | ||
| Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins | Q33689010 | ||
| Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock | Q35052743 | ||
| Reversing established sepsis with antagonists of endogenous high-mobility group box 1. | Q35122534 | ||
| A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin | Q35752891 | ||
| A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. | Q35990737 | ||
| High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity | Q36990574 | ||
| Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE | Q37019629 | ||
| RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease | Q37106503 | ||
| HMGB1 develops enhanced proinflammatory activity by binding to cytokines. | Q40016396 | ||
| Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). | Q40230859 | ||
| Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein | Q40609759 | ||
| Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells | Q40686939 | ||
| Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation. | Q42984601 | ||
| High mobility group 1 B-box mediates activation of human endothelium | Q45182292 | ||
| Sulfoglycolipids bind to adhesive protein amphoterin (P30) in the nervous system | Q48545696 | ||
| High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes | Q50335841 | ||
| High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis | Q58876474 | ||
| P433 | issue | 3 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 655-662 | |
| P577 | publication date | 2009-06-29 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation | |
| P478 | volume | 86 |
| Q38748673 | 2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity. |
| Q45868008 | Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. |
| Q51886367 | Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. |
| Q64092947 | Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome |
| Q35515960 | Alarmin function of galectin-9 in murine respiratory tularemia |
| Q24324028 | An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor |
| Q35076030 | Anti-HMGB1 monoclonal antibody ameliorates immunosuppression after peripheral tissue trauma: attenuated T-lymphocyte response and increased splenic CD11b (+) Gr-1 (+) myeloid-derived suppressor cells require HMGB1. |
| Q37382986 | Attenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is toll-like receptor 2-dependent |
| Q92494685 | Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis |
| Q35319588 | Biophysical effects in off-resonant gold nanoparticle mediated (GNOME) laser transfection of cell lines, primary- and stem cells using fs laser pulses |
| Q54091637 | Boxb mediate BALB/c mice corneal inflammation through a TLR4/MyD88-dependent signaling pathway in Aspergillus fumigatus keratitis. |
| Q35902972 | Cancer and innate immune system interactions: translational potentials for cancer immunotherapy |
| Q40641396 | Cell death and inflammation: the case for IL-1 family cytokines as the canonical DAMPs of the immune system |
| Q27008742 | Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexes |
| Q30583559 | Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling |
| Q37638028 | Changes in protein expression after treatment with Ancylostoma caninum excretory/secretory products in a mouse model of colitis |
| Q36857361 | Characterization of the structural and protein recognition properties of hybrid PNA-DNA four-way junctions |
| Q33987148 | Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal p |
| Q39761212 | Co-inhibitory molecules: Controlling the effectors or controlling the controllers? |
| Q38154796 | DAMPs activating innate and adaptive immune responses in COPD. |
| Q37535386 | DAMPs and inflammatory processes: the role of redox in the different outcomes |
| Q48269154 | Damage-associated molecular patterns and their role as initiators of inflammatory and auto-immune signals in systemic lupus erythematosus. |
| Q38173348 | Danger signals in the initiation of the inflammatory response after myocardial infarction |
| Q38055437 | Danger-associated molecular patterns (DAMPs) in acute lung injury |
| Q34805688 | Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice |
| Q36089059 | Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. |
| Q48093757 | Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome. |
| Q26828596 | Emerging role of HMGB1 in fibrotic diseases |
| Q37446034 | Emerging role of high-mobility group box 1 (HMGB1) in liver diseases |
| Q35541859 | Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice |
| Q35494888 | Enhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis. |
| Q39743331 | Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease |
| Q40084796 | Expression of the Receptor for Advanced Glycation End Products in Epicardial Fat: Link with Tissue Thickness and Local Insulin Resistance in Coronary Artery Disease |
| Q27334837 | Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury |
| Q28387701 | Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo |
| Q94544471 | Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? |
| Q27314507 | Extracellular administration of BCL2 protein reduces apoptosis and improves survival in a murine model of sepsis |
| Q27025545 | Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain |
| Q42239800 | Follicular dendritic cell makes environmental sense. |
| Q87926738 | Fragmented hyaluronan has no alarmin function assessed in arthritis synovial fibroblast and chondrocyte cultures |
| Q34635334 | Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia |
| Q86689305 | HMGB1 Binds to Lipoteichoic Acid and Enhances TNF-α and IL-6 Production through HMGB1-Mediated Transfer of Lipoteichoic Acid to CD14 and TLR2 |
| Q37326998 | HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-κB signaling pathways. |
| Q35193905 | HMGB1 and microparticles as mediators of the immune response to cell death |
| Q51641769 | HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1/2. |
| Q43844401 | HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion. |
| Q34622835 | HMGB1 in health and disease |
| Q35953553 | HMGB1 is a therapeutic target for sterile inflammation and infection |
| Q37622874 | HMGB1 localization during experimental periodontitis |
| Q52337005 | HMGB1/IL-1β complexes in plasma microvesicles modulate immune responses to burn injury. |
| Q47719384 | HMGB1/IL-1β complexes regulate neuroimmune responses in alcoholism |
| Q37980335 | HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease |
| Q42326311 | HMGB1: a smoking gun in lupus nephritis? |
| Q37825717 | Heat shock proteins and high mobility group box 1 protein lack cytokine function |
| Q36322388 | High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule |
| Q35557813 | High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus |
| Q34153150 | High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes |
| Q24604370 | High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor |
| Q39831106 | High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. |
| Q35136716 | High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls |
| Q35192858 | High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome |
| Q48331221 | High-Mobility Group Box 1 Upregulates MUC5AC and MUC5B Expression in Primary Airway Epithelial Cells. |
| Q45863504 | High-mobility group box 1 (HMGB1) as a master regulator of innate immunity |
| Q38888020 | High-mobility group box 1 accelerates lipopolysaccharide-induced lung fibroblast proliferation in vitro: involvement of the NF-κB signaling pathway |
| Q36174486 | High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway |
| Q35891564 | High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5. |
| Q34203942 | High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus |
| Q41394835 | IL-1β/HMGB1 complexes promote The PGE2 biosynthesis pathway in synovial fibroblasts |
| Q35037009 | Immune dysregulation by the rheumatoid arthritis shared epitope |
| Q36032021 | Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection |
| Q35561332 | Increased HMGB1 expression and release by mononuclear cells following surgical/anesthesia trauma |
| Q41160207 | Inflammation and epilepsy: the foundations for a new therapeutic approach in epilepsy? |
| Q34043446 | Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected] |
| Q38313261 | Interaction of HMG proteins and H1 with hybrid PNA-DNA junctions |
| Q51017414 | Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice |
| Q37943809 | Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis |
| Q50228683 | Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition |
| Q38066361 | Ischaemia-reperfusion injury in liver transplantation--from bench to bedside |
| Q36562901 | Life after death: targeting high mobility group box 1 in emergent cancer therapies |
| Q55425512 | Ligation of free HMGB1 to TLR2 in the absence of ligand is negatively regulated by the C-terminal tail domain. |
| Q37363183 | Lipopolysaccharide Attenuates Induction of Proallergic Cytokines, Thymic Stromal Lymphopoietin, and Interleukin 33 in Respiratory Epithelial Cells Stimulated with PolyI:C and Human Parechovirus |
| Q37888774 | Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation |
| Q38625302 | Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation |
| Q34994835 | Mechanical ventilation enhances HMGB1 expression in an LPS-induced lung injury model |
| Q39095935 | Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis |
| Q27016054 | Microparticles as mediators and biomarkers of rheumatic disease |
| Q37363894 | Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations |
| Q38067757 | Modeling nuclear molecule release during in vitro cell death. |
| Q26830597 | Mucins and toll-like receptors: kith and kin in infection and cancer |
| Q42238295 | Mycoplasma superantigen initiates a TLR4-dependent Th17 cascade that enhances arthritis after blocking B7-1 in Mycoplasma arthritidis-infected mice |
| Q26746478 | NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? |
| Q40111437 | Necroptosis in the periodontal homeostasis: Signals emanating from dying cells. |
| Q52373347 | Neuroinflammation in Response to Intracerebral Injections of Different HMGB1 Redox Isoforms. |
| Q36711791 | Oxidized extracellular DNA as a stress signal in human cells |
| Q58326494 | Partially-desulfated heparin improves survival inPseudomonaspneumonia by enhancing bacterial clearance and ameliorating lung injury |
| Q38965371 | Porcine reproductive and respiratory syndrome virus infection triggers HMGB1 release to promote inflammatory cytokine production |
| Q39674959 | Preconditioning With High Mobility Group Box 1 (HMGB1) Induces Lipoteichoic Acid (LTA) Tolerance |
| Q34315899 | Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes |
| Q37246964 | Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis |
| Q50956450 | Proteomic analysis of human epithelial lining fluid by microfluidics-based nanoLC-MS/MS: a feasibility study |
| Q38188456 | Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus |
| Q35044718 | Red blood cells induce necroptosis of lung endothelial cells and increase susceptibility to lung inflammation. |
| Q35885013 | Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1) |
| Q36605862 | Reduced soluble RAGE is associated with disease severity of axonal Guillain-Barré syndrome |
| Q36513532 | Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β |
| Q49333290 | Saquinavir Ameliorates Liver Warm Ischemia-Reperfusion-Induced Lung Injury via HMGB-1- and P38/JNK-Mediated TLR-4-Dependent Signaling Pathways |
| Q34390999 | Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. |
| Q40239891 | Synergistic effect of high-mobility group box-1 and lipopolysaccharide on cytokine induction in bovine peripheral blood mononuclear cells |
| Q42650240 | Synovial fibroblasts in 2017. |
| Q34667534 | TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant |
| Q35085962 | TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis |
| Q38781354 | TLRs, future potential therapeutic targets for RA. |
| Q27009518 | Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches |
| Q34769562 | The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis. |
| Q36321838 | The HMGB1 signaling pathway activates the inflammatory response in Schwann cells. |
| Q33745462 | The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation |
| Q35056726 | The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis |
| Q30505780 | The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1. |
| Q64096078 | The Role of Mitochondrial Damage-Associated Molecular Patterns in Chronic Neuroinflammation |
| Q38131032 | The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus. |
| Q51274805 | The damage-associated molecular pattern HMGB1 is elevated in human alcoholic hepatitis, but does not seem to be a primary driver of inflammation. |
| Q38979165 | The danger from within: alarmins in arthritis |
| Q38555406 | The danger model: questioning an unconvincing theory |
| Q33851482 | The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation |
| Q42381172 | The danger-associated molecular pattern HMGB1 mediates the neuroinflammatory effects of methamphetamine. |
| Q38195181 | The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo |
| Q43072756 | The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death |
| Q38013050 | The impact of infection and tissue damage in solid-organ transplantation |
| Q38150096 | The interplay between pathogen-associated and danger-associated molecular patterns: an inflammatory code in cancer? |
| Q38116712 | The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer |
| Q37047827 | The origin and properties of extracellular DNA: from PAMP to DAMP. |
| Q34128646 | The oxidative stress product carboxyethylpyrrole potentiates TLR2/TLR1 inflammatory signaling in macrophages |
| Q37712484 | The prelude on novel receptor and ligand targets involved in the treatment of diabetes mellitus. |
| Q39118808 | The role of neuroimmune signaling in alcoholism |
| Q27010599 | The translocation of nuclear molecules during inflammation and cell death |
| Q47147432 | Toll-Like Receptor 4 Signalling and Its Impact on Platelet Function, Thrombosis, and Haemostasis. |
| Q35550677 | Toll-like receptor 4 activation in cancer progression and therapy |
| Q36145679 | Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation |
| Q33645274 | Toll-like receptor signaling and stages of addiction |
| Q37954396 | Toll-like receptors and diabetes: a therapeutic perspective |
| Q37091891 | Toll-like receptors in atherosclerosis |
| Q27028225 | Vitreous mediators in retinal hypoxic diseases |
| Q38556787 | rhHMGB1 drives osteoblast migration in a TLR2/TLR4- and NF-κB-dependent manner |
Search more.